Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIIP vs Injectable Insulin in Type 1 Diabetes
NCT00447213Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2007
- Primary completion
- May 2008
- Modality
- Biologic
- Countries
- 2
01
Overview
A Phase 3 trial of insulin human in type 1 diabetes mellitus (T1D), sponsored by Eli Lilly and Company. Started Apr 2007; status: completed.
02
Drugs
insulin human
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00447213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00447213.